Official Journal Publication

Journal of PharmTechNova

Short Name: JPTN• ISSN: 3139-9258• Peer-Reviewed Open Access

2026Volume 1 Issue 02, Pages 50-72• Published: July 15, 2026

Development and Optimization of a Feronia elephantum Leaf Extract Ointment: A QbD-Based Approach for Enhanced Anti-Inflammatory Activity

Contributing Authors
Inzamamul Haq Ameer ShaikhSharad D. TayadeArfin S. TamboliKedar Kailas GanjareVijay S. BorkarJyoti Bhushan Khedekar
Digital Object Identifier (DOI):https://doi.org/10.66220/gbpwf155

Abstract

Feronia elephantum possesses significant therapeutic potential owing to its rich phytochemical composition and traditional use in inflammatory disorders. The present study aimed to develop, optimize, and evaluate a topical herbal ointment containing Feronia elephantum leaf extract using a Quality by Design (QbD) approach. The hydroalcoholic extract was prepared by maceration and characterized using FTIR, DSC, and UV spectroscopy. FTIR analysis confirmed the presence of phenolic and flavonoid constituents, while DSC revealed a characteristic endothermic peak at 123.92°C. UV analysis showed a maximum absorption wavelength (λmax) at 275 nm. Extract–excipient compatibility studies demonstrated the absence of significant interactions between the extract and selected excipients. A 2³ full factorial design was employed using cetostearyl alcohol, lanolin, and liquid paraffin as critical material attributes, while viscosity and percentage drug release were selected as critical quality attributes. Eight formulations were prepared and evaluated for physicochemical properties, drug content, spreadability, extrudability, homogeneity, in vitro drug release, and anti-inflammatory activity. The formulations exhibited viscosities ranging from 1450 to 2520 cP and cumulative drug release between 75.2% and 91.8%. Statistical analysis showed that cetostearyl alcohol and lanolin significantly influenced both viscosity and drug release (p < 0.0001). The optimized formulation (F4) demonstrated a viscosity of 2105 cP and drug release of 82.4%. In vitro anti-inflammatory evaluation using the HRBC membrane stabilization method showed that the ointment formulation produced 29.0 ± 1.0% and 46.0 ± 1.0% membrane protection at 200 and 400 mg/mL, respectively, compared with 25.0 ± 1.0% and 41.0 ± 1.0% for the crude extract. Accelerated stability studies indicated minimal changes in pH (6.45–6.61), viscosity (2105–2102 cP), and drug content (95.86–95.30%) over three months. In conclusion, the QbD-optimized Feronia elephantum ointment exhibited satisfactory physicochemical characteristics, controlled drug release, enhanced anti-inflammatory activity, and good stability, indicating its potential as an effective topical herbal formulation for inflammatory conditions.

Export Citation

Generate ready-to-use citations in standard scientific formats

Ameer Shaikh, I. H., D. Tayade, S., S. Tamboli, A., Kailas Ganjare, K., S. Borkar, V., & Bhushan Khedekar, J. (2026). Development and Optimization of a Feronia elephantum Leaf Extract Ointment: A QbD-Based Approach for Enhanced Anti-Inflammatory Activity. Journal of PharmTechNova, Vol. 1(No. 02), pp. 50-72. https://doi.org/10.66220/gbpwf155

Cited References

33 References
  1. 01.

    1. Drosopoulou K, Kosheleva RI, Ofrydopoulou A, Tsoupras A, Mitropoulos A. Topical and Transdermal Delivery of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) for Inflammation and Pain: Current Trends and Future Directions in Delivery Systems, Processes 2025, 13(3), 907; doi: 10.3390/pr13030907.

  2. 02.

    2. Tiwari M. The role of serratiopeptidase in the resolution of inflammation. Asian J Pharm Sci, 2017 May;12(3):209-215. doi: 10.1016/j.ajps.2017.01.003.

  3. 03.

    3. Al-Khayri JM, Sahana GR, Nagella P, Joseph BV, Alessa FM, Al-Mssallem MQ. Flavonoids as Potential Anti-Inflammatory Molecules: A Review. Molecules 2022, 27(9), 2901; doi: 10.3390/molecules27092901.

  4. 04.

    4. Dixit K, Chauhan B, Jain R. Anti-Inflammatory Potential of Medicinal Plants in the Management of Inflammatory Diseases: A Review of Mechanisms and Bioactive Compounds. J. Drug Deliv. Ther., 15, 330–40 (2025). doi: 10.22270/jddt.v15i6.7203.

  5. 05.

    5. Muthulakshmi A, Margret RJ, Mohan VR. Antiulcer effect of Feronia elephantum correa leaf and bark extract in indomethacin induced albino rats. J. Appl. Pharm. Sci., 3, (2013):(4 Suppl 1):S71-S74. doi: 10.7324/JAPS.2013.34.S1.

  6. 06.

    6. Sharma M, Nagdev S, Bhurat M, Dhankani A, Jain M, Mude G. Feronia elephantum Correa: A Potential Traditional Drug. Int. J. Ayurvedic Med., 12(3), 482–84 (2021). doi: 10.47552/ijam.v12i3.1965.

  7. 07.

    7. Diarti MW, Harmi KYS, Ahsani DN. Protective effect of ethanolic Feronia elephantum Correa fruit extract on high-fat diet induced steatohepatitis in rats. Universa Med., 40, 36–44 (2021). doi: 10.18051/univmed.2021.v40.36-44.

  8. 08.

    8. Souto EB, Cano A, Martins-Gomes C, Coutinho TE, Zielińska A, Silva AM. Microemulsions and Nanoemulsions in Skin Drug Delivery. Bioengineering, 9(4), 158, (2022). doi: 10.3390/bioengineering9040158.

  9. 09.

    9. Mousavi-Simakani SM, Azadi A, Tanideh N, Omidifar N, Ghasemiyeh P, Mohammadi-Samani S. Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies. Adv. Pharm. Bull., 13(4), 761–71 (2023). doi: 10.34172/apb.2023.083.

  10. 10.

    10. Al-Jarsha HYM, Ghareeb MM. Validation of UV-visible spectrophotometric method for niclosamide in different media. Trop. J. Pharm. Res., 23(5), 871–80 (2024). doi: 10.4314/tjpr.v23i5.9.

  11. 11.

    11. Limbachiya P, Patel V, Rami G, Vora J. Chitosan-dibenzylideneacetone based Schiff base: Evaluation of antimicrobial activity and in-vitro cytotoxicity on MCF-7 and L-132. Int. J. Biol. Macromol., 250, (2023). doi: 10.1016/j.ijbiomac.2023.126268.

  12. 12.

    12. Mohandoss S, Ahmad N, Rizwan Khan M, Rok Lee Y. Physicochemical characterization, solubility enhancement, molecular docking, and antibacterial activity of inclusion complexes of naproxen/β-cyclodextrin derivatives: A comparative study. J. Mol. Liq., 385, (2023). doi: 10.1016/j.molliq.2023.122411.

  13. 13.

    13. Charoo NA, Shamsher AAA, Zidan AS, Rahman Z. Quality by design approach for formulation development: A case study of dispersible tablets. Int. J. Pharm., 423, 167–78 (2012). doi: 10.1016/j.ijpharm.2011.12.024.

  14. 14.

    14. Mokhtar HI, Abdel-Salam RA, Hadad GM. Design Space Calculation by In Silico Robustness Simulation with Modeling Error Propagation in QbD Framework of RP-HPLC Method Development. Chromatographia, 78, 457–66 (2015). doi: 10.1007/s10337-015-2858-2.

  15. 15.

    15. Mahfuz ul Alam A, Mamun IR, Nahar N, Shoeb M. A Quality by Design (QBD) approach for the development and validation of RP-HPLC method for the quantification of linagliptin tablets. Int. J. Pharm. Chem. Anal., 10(4), 281–9 (2023). doi: 10.18231/j.ijpca.2023.047.

  16. 16.

    16. Alshahrani MS, Alshahrani WK, Assiri SAA, Alasmari WO, Alqahtani AA. Green Chemistry-Based Extraction , Phytochemical Screening , and Evaluation of Anti-Inflammatory Activity of Aerva lanata. J. Phytopharm. Adv. Chem., 01(1), 45–53 (2026). doi: 10.66220/zwjben85.

  17. 17.

    17. Khan SL, Bakshi V. Physicochemical characterization , GC – MS profiling , and computational evaluation of ailanthus excelsa hydroalcoholic extract against mutant EGFR. Chem. Rev. Lett., 9, 358–76 (2026). doi: 10.22034/crl.2026.571902.1771.

  18. 18.

    18. Muhammed A, Yakubu J, Maikau FU, Gimba FM, Tanko U, Ibrahim S. Phytochemical Screening , Isolation , Characterization and Antimicrobial Evaluation of Syzygium cumini Leaf Extracts. J. Chem. Technol., 2, 17–25 (2026). doi: 10.22034/jchemtech.2025.542808.1019.

  19. 19.

    19. DA B. Exploring Diverse Techniques for Phytochemical Extraction from Plant Sources A Comprehensive Review. Int. J. Pharmacogn. Chinese Med., 8(1), 1–11 (2024). doi: 10.23880/ipcm-16000266.

  20. 20.

    20. Altemimi A, Lakhssassi N, Baharlouei A, Watson DG, Lightfoot DA. Phytochemicals: Extraction, isolation, and identification of bioactive compounds from plant extracts. Plants (Basel). 2017 Sep 22;6(4):42. doi: 10.3390/plants6040042.

  21. 21.

    21. Boyaci IH, Genis HE, Guven B, Tamer U, Alper N. A novel method for quantification of ethanol and methanol in distilled alcoholic beverages using Raman spectroscopy. J. Raman Spectrosc., 43, 1171–6 (2012). doi: 10.1002/jrs.3159.

  22. 22.

    22. Caruso R, Gambino GL, Scordino M, Sabatino L, Traulo P, Gagliano G. Gas chromatographic quantitative analysis of methanol in wine: Operative conditions, optimization and calibration model choice. Nat. Prod. Commun., 6, 1939–43 (2011). doi: 10.1177/1934578x1100601237.

  23. 23.

    23. Patel P, Ahir K, Patel V, Manani L, Patel C. Drug-Excipient compatibility studies : First step for dosage form development. Pharma Innov. J., 4(5), 14–20 (2015).

  24. 24.

    24. Pramod K, Suneesh CV, Shanavas S, Ansari SH, Ali J. Unveiling the compatibility of eugenol with formulation excipients by systematic drug-excipient compatibility studies. J. Anal. Sci. Technol., 6, 34(2015). doi: 10.1186/s40543-015-0073-2.

  25. 25.

    25. Fisher F, Africa C, Klaasen J, Fisher R. South African Medicinal Plants Traditionally Used for Wound Treatment: An Ethnobotanical Systematic Review. Plants (Basel), 2025, 14(5):818. doi: 10.3390/plants14050818.

  26. 26.

    26. Andrade C. Understanding Factorial Designs, Main Effects, and Interaction Effects: Simply Explained with a Worked Example. Indian J. Psychol. Med., 46, 175–7 (2024). doi: 10.1177/02537176241237066.

  27. 27.

    27. Jankovic A, Chaudhary G, Goia F. Designing the design of experiments (DOE) – An investigation on the influence of different factorial designs on the characterization of complex systems. Energy Build., 250, (2021). doi: 10.1016/j.enbuild.2021.111298.

  28. 28.

    28. Ajith K, Pillai AS, Muthu Vijayan Enoch IV, Sharifpur M, Solomon AB, Meyer JP. Effect of the non-electrically conductive spindle on the viscosity measurements of nanofluids subjected to the magnetic field. Colloids Surfaces A Physicochem. Eng. Asp., 628, (2021). doi: 10.1016/j.colsurfa.2021.127252.

  29. 29.

    29. Vishvnath G, Jain UK. Quantitative analysis of piperine in ayurvedic formulation by UV Spectrophotometry. Int. J., 2(2), 58–61 (2011).

  30. 30.

    30. Bao Q, Shen J, Jog R, Zhang C, Newman B, Wang Y, Choi S, Burgess DJ. In vitro release testing method development for ophthalmic ointments. Int. J. Pharm., 526, 145–56 (2017). doi: 10.1016/j.ijpharm.2017.04.075.

  31. 31.

    31. Askarizadeh M, Esfandiari N, Honarvar B, Sajadian SA, Azdarpour A. Kinetic Modeling to Explain the Release of Medicine from Drug Delivery Systems. ChemBioEng Rev., 10, 1006–49 (2023). doi: 10.1002/cben.202300027.

  32. 32.

    32. González-González O, Ramirez IO, Ramirez BI, O’Connell P, Ballesteros MP, Torrado JJ, Serrano DR. Drug Stability: ICH versus Accelerated Predictive Stability Studies. Pharmaceutics, 14(11):2324, (2022). doi: 10.3390/pharmaceutics14112324.

  33. 33.

    33. Truong DH, Nguyen DH, Ta NTA, Bui AV, Do TH, Nguyen HC. Evaluation of the use of different solvents for phytochemical constituents, antioxidants, and in vitro anti-inflammatory activities of severinia buxifolia. J. Food Qual., 2019:8178294. doi: 10.1155/2019/8178294.

Suggested & Related Publications

Articles in related pharmaceutical, biomedical, and life sciences research on PharmSciGate

Explore Directory →
JPTN2026 • pp. 126-151

Development and Optimization of a Luliconazole Film-Forming Topical Spray Using a Quality by Design Approach

Ghadage, Avanti S.; Pomaje, Madan D.; Patil, Ashwini B.

Luliconazole is a topical antifungal agent used in the management of superficial fungal infections. Film-forming topical sprays may provide convenient application and facilitate the formation of a uniform drug-containing film at the site of administration. The present study aimed to develop and optimize a Luliconazole film-forming spray using a Quality by Design (QbD) approach. A (2^3) full factorial design was employed to investigate the effects of Hydroxypropyl Cellulose (HPC), Eudragit® RS100, and PEG 400 on critical formulation responses, with drying time and viscosity selected as dependent variables. Eight formulations (F1–F8) were prepared by varying the concentrations of the selected formulation components and evaluated for appearance, film formation, pH, viscosity, drying time, spray angle, film thickness, folding endurance, stickiness, washability, leak test, drug content, and in vitro drug diffusion. Statistical analysis and response-surface methodology were used for formulation optimization. The prepared formulations were clear and homogeneous and exhibited acceptable film-forming properties. Drying time ranged from 3.8 to 8.2 min, while viscosity ranged from 162 to 438 cP. The formulation variables significantly influenced the investigated responses. Formulation F8, containing 1% w/v HPC, 4% w/v Eudragit® RS100, and 5% v/v PEG 400, was selected as the optimized formulation. F8 exhibited a drying time of 5.1 min, viscosity of 304 cP, and spray angle of 83.6°. It produced a uniform, transparent, non-sticky, and adherent film, with drug content of 99.2 ± 0.8%. The QbD approach enabled systematic optimization of the Luliconazole film-forming spray and identified F8 as a promising formulation with desirable spray and film-forming characteristics for topical drug delivery.

JPTN2026 • pp. 152-158

In Vitro Antifungal Evaluation of a Berberine–Ellagic Acid Phytosome-Based Hydrogel Against Candida albicans

Narvekar, Namita Gajanan; Panda, Simachal; Jagtap, Vijay Arjun

Candida albicans is an important fungal pathogen associated with superficial and opportunistic infections, creating a need for effective topical antifungal delivery systems. The present study aimed to evaluate the in vitro antifungal activity of an optimized berberine–ellagic acid (B+E) phytosome-based hydrogel against C. albicans. The optimized B+E phytosomes were incorporated into a Carbopol 940 and HPMC K15-based hydrogel matrix to develop a topical formulation. The antifungal activity was evaluated using the agar well diffusion method against C. albicans. The study included the pure B+E combination, optimized B+E phytosome hydrogel, ketoconazole as the standard antifungal drug, blank hydrogel, and normal control. Antifungal activity was assessed by measuring the zone of inhibition (ZOI). The optimized B+E phytosome hydrogel exhibited a ZOI of 23.54 mm, compared with 15.29 mm for the pure B+E combination and 26.64 mm for the standard antifungal drug. Thus, the phytosome-based hydrogel demonstrated an approximately 53.89% improvement in inhibition-zone diameter compared with pure B+E and achieved approximately 88.36% of the inhibition produced by the standard treatment. The optimized formulation also showed high drug content, with 95.86 ± 0.52% for berberine and 94.97 ± 0.61% for ellagic acid. The blank hydrogel and normal control showed no detectable inhibition. The enhanced activity may be attributed to improved dispersion and distribution of B+E within the phytosomal system and favorable diffusion characteristics of the hydrogel matrix. Overall, the findings demonstrate the potential of B+E phytosome-based hydrogel as a promising topical antifungal delivery system against C. albicans. Further in vivo and mechanistic studies are warranted.

JPPAC2026 • pp. 212-218

Comparative In Vitro Evaluation of Berberine–Chlorogenic Acid and Its Phytosome-Based Hydrogel Against Candida albicans

Narvekar, Namita Gajanan; Panda, Simachal; Jagtap, Vijay Arjun

Candida albicans is an important fungal pathogen associated with superficial and opportunistic infections, highlighting the need for effective topical antifungal formulations. The present study aimed to evaluate the in vitro antifungal activity of an optimized berberine–chlorogenic acid (B+CA) phytosome-based hydrogel against C. albicans and compare its performance with the pure B+CA combination and ketoconazole. The optimized F1 formulation contained berberine and chlorogenic acid in a 1:1 ratio and was evaluated using the agar well diffusion method. Ketoconazole served as the standard antifungal drug, while normal control and blank hydrogel were included as controls. Antifungal activity was assessed by measuring the zone of inhibition (ZOI) following incubation. The results demonstrated that the B+CA phytosome-based hydrogel produced a ZOI of 22.90 mm, whereas the pure B+CA combination exhibited a ZOI of 18.50 mm. The optimized F1 formulation showed an approximately 23.8% greater inhibition-zone diameter than the pure combination, indicating improved antifungal performance following phytosome-based incorporation into the hydrogel matrix. Ketoconazole demonstrated the highest antifungal activity, with a ZOI of 31.44 mm. Neither the normal control nor the blank hydrogel produced a measurable inhibition zone. The enhanced activity of F1 may be associated with improved dispersion and presentation of the active constituents and the contribution of the hydrogel matrix to formulation retention and diffusion. In conclusion, the findings support the potential of the B+CA phytosome-based hydrogel as a promising topical antifungal formulation. Further safety, skin compatibility, and in vivo studies are required to establish its therapeutic suitability.

Full-Text Access

Access Type: Open Access
License:CC BY-NC 4.0
Language:en
Publishing Journal

Journal of PharmTechNova

A platform for pioneering research in novel pharmaceutical technology, biotechnology, drug delivery, clinical translation, and computational design.

ISSN:3139-9258
DOI Prefix:10.66220
Visit Journal Portal
Indexed on PharmSciGate by SPBSRF

This peer-reviewed publication is indexed directly from the publisher repository adhering to Open Archives Initiative (OAI-PMH) metadata standards, Crossref DOI schema, and Google Scholar Highwire Press protocols.